SIAH2 and non-small cell lung carcinoma: MiR-30-5p family interaction with PIK3R2-SIAH2 is considered as a potential therapeutic target for NSCLC, especially LUAD, and SIAH2 is an E3 ubiquitin-protein ligase that mediates the degradation of target proteins (79).